SCHEMBL1135033

SCHEMBL1135033

CCN(CC)CCNC(=O)c1ccc([Sn](C)(C)C)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ SLC22A2 O15244 1/20 0.57
▸ SLC22A1 O15245 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ ACHE P22303 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ BLM P54132 2/20 0.56
▸ PMP22 Q01453 1/20 0.56
▸ NFKB1 P19838 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ POLB P06746 2/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ SCN1A P35498 1/20 0.50
▸ SCN2A Q99250 1/20 0.50
▸ SCN3A Q9NY46 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12438415 0.82 KDM4E (0.63) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL1135003 0.82 ALDH1A1 (0.61) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL13426202 0.82 ALDH1A1 (0.61) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL12438389 0.81 LMNA (0.59) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL1134961 0.81 LMNA (0.59) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL12438405 0.81 ALDH1A1 (0.59) ALDH1A1LMNASLC22A2SLC22A1TSHR
Hydrochloric Acid SCHEMBL2444193 0.81 LMNA (0.62) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL1231713 0.81 ALDH1A1 (0.68) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL29369961 0.81 LMNA (0.59) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL1134988 0.81 LMNA (0.59) ALDH1A1LMNASLC22A2SLC22A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178396-A1 Nicotinamide Derivatives CRC FOR BIOMEDICAL IMAGING DEVELOPMENT LTD. (AU) 2011-07-21 — — US disclosed
EP-2285778-A1 NICOTINAMIDE DERIVATIVES CRC for Biomedical Imaging Development Ltd (AU) 2011-02-23 — — EP disclosed
WO-2009129573-A1 NICOTINAMIDE DERIVATIVES AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2009-10-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178396-A1 Nicotinamide Derivatives NAMPT, NNT, NNMT ALDH1A1 883/4885LMNA 2345/4885SLC22A2 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback